Associations Between Dental Anomalies and Ocular, Cutaneous and Skin Appendages Features

November 14, 2025 updated by: Andrea Scribante, University of Pavia

A Clinical Investigation Into the Co-occurrence of Dental Anomalies With Ocular and Cutaneous Features

Considering recent literature, it is possible to hypothesise a link between dental anomalies and ocular and/or cutaneous findings, given the existence of shared genetic and developmental mechanisms between these two anatomical areas. Both the eye and teeth develop from ectodermal and mesenchymal tissues, involving common molecular signalling pathways such as Wnt, BMP and PAX. Genetic variants affecting these pathways can therefore determine combined phenotypes, such as congenital cataracts associated with dental agenesis or enamel malformations. Some rare genetic syndromes, such as Nance-Horan syndrome and oculofacio-cardio-dental (OFCD) syndrome, support the hypothesis of a systemic correlation between odontogenesis and ocular development. In a previous study on congenital cataracts, nearly 10% of probands with variants in the BCOR, CWC27, IFIH1, NHS, and PAX6 genes had various dental abnormalities. Therefore, exploring the possible connection between eye and dental diseases may not only facilitate early and multidisciplinary diagnosis, but also open up new perspectives in genetic research and the development of personalised therapeutic approaches, for which whole genome sequencing (WGS) appears to be the first choice for investigating non-syndromic forms. Therefore, the current clinical study aims to identify variants in genes common to eye diseases and dental anomalies (agenesis, supernumerary teeth, Hutchinson's teeth, mulberry molars) in orthodontic patients over the age of 12 with dental anomalies who are about to begin orthodontic treatment or who are attending routine check-ups at the Orthodontics and Paediatric Dentistry Unit, Department of Clinical, Surgical, Diagnostic and Paediatrics Sciences at the University of Pavia who have a family history of ocular and cutaneous manifestations or presenting at the same time dental, ocular and/or cutaneous anomalies. Patients who are eligible will be invited to participate in the study. After signing the informed consent form, the Case Report Form will be completed to collect the data of interest for the study; previous medical reports will be asked to patients or parents/legal guardians in case of minors to ascertain ocular and cutaneous pathologies; a buccal swab will be taken to collect a DNA sample that will be analysed with Next Generation Sequencing. In addition, cephalometric evaluations will be performed if lateral teleradiographs will be available, if already performed in accordance with Good Clinical Practice for the purposes of orthodontic assessment of patients.

Study Overview

Detailed Description

Considering recent literature, a possible link between ocular diseases and dental anomalies could be hypothesized, given the existence of shared genetic and developmental mechanisms between these two anatomical districts. Both the eye and the teeth develop from ectodermal and mesenchymal tissues, involving common molecular signaling pathways such as Wnt, BMP, and Pax. Genetic variants affecting these pathways may therefore result in combined phenotypes, such as congenital cataract associated with tooth agenesis or enamel malformations.

Certain rare genetic syndromes, such as Nance-Horan syndrome and Oculo-Facio-Cardio-Dental syndrome (OFCD), support the hypothesis of a systemic correlation between odontogenesis and eye development. In a previous study on congenital cataract, almost 10% of probands with variants in BCOR, CWC27, IFIH1, NHS, and PAX6, various dental anomalies were observed. Therefore, exploring the possible connection between ocular and dental diseases may not only facilitate early and multidisciplinary diagnosis but also open new perspectives in genetic research and the development of personalized therapeutic approaches, for which Whole Genome Sequencing seems the first choice option to investigate non-syndromic forms.

Therefore, the current observational study aims at identifying variants in common genes for ocular pathologies and dental anomalies (agenesis, supernumeraries, Hutchinson teeth, Mulberry molars) in orthodontic patients with family history of ocular manifestations, to hypothesize a deeper connection between teeth and eyes. An electronic search will be performed on the database of the Unit of Orthodontics and Pediatric Dentistry, Section of Dentistry, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences of the University of Pavia to find patients presenting tooth abnormalities. Patients will be contacted by phone to collect information on their family history of ocular pathology. If the anamnesis will be positive, they will be invited to be enrolled in the study, and a buccal swab will be perfomed to collect DNA sample that will be analysed with Next Generation Sequencing. The same procedure will be performed with patients presenting for oral care at the same Unit prospectively. Additionally, skeletal patterns will be evaluated through cephalometric analysis if lateral cephalometric radiographs will be present. As secondary outcome, anomalies on skin appendages will be evaluated, considering the common ectodermal origin between skin and teeth.

Study Type

Interventional

Enrollment (Estimated)

5

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Lombardy
      • Pavia, Lombardy, Italy, 27100
        • Unit of Orthodontics and Pediatric Dentistry - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Pediatrics - University of Pavia
        • Contact:
      • Pavia, Lombardy, Italy, 27100
        • Unit of Medical Genetics, Department of Molecular Medicine, University of Pavia
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Study Population

Orthodontic patients undergone orthopedic/orthodontic treatment and fulfilling inclusion criteria.

Description

Inclusion Criteria:

  • Supernumerary teeth
  • oligodontia
  • screw driver sharped incisors
  • Hutchinson's teeth
  • mulberry molars
  • tooth agenesis
  • congenital cataract, keratitis, keratoconus, corneal dystrophies, ectopia lentis, glaucoma, retinitis pigmentosa, coloboma and aniridia in probands or relatives
  • skin appendages anomalies in probands or relatives

Exclusion Criteria:

  • Previous orthodontic, restorative, endodontic, prosthetic and surgical treatment that could alter tooth morphology and position

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Orthodontic patients
Patients fulfilling the inclusion criteria will undergo blood sampling
Cephalometric tracing will be performed on lateral cephalometric radiographs if present and not taken on purpose for the study
Genetic testing will be performed to find variants in genes involving congenital cataract and/or ocular diseases (keratitis, keratoconus, corneal dystrophies, ectopia lentis, glaucoma, retinitis pigmentosa, coloboma and aniridia) and dental anomalies (tooth agenesis, supernumerary teeth, Hutchinson teeth, mulberry molars). Cutaneous appendage anomalies will be also evaluated in clinical history for ascertaining ectodermal diplasia.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Presence of variants in common genes for dental anomalies, ocular diseases and cutaneous/skin appendages features
Time Frame: Baseline
Whole Genome Sequencing will be used to find pathogenetic variants
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SNA angle
Time Frame: Baseline
Angle between the sella, nasion and A point measured on lateral cephalometric radiograph
Baseline
SNB angle
Time Frame: Baseline
Angle between the sella, nasion and B point measured on lateral cephalometric radiograph
Baseline
ANB angle
Time Frame: Baseline
Angle between point A, the nasion and point B measured on lateral cephalometric radiograph
Baseline
SN plane
Time Frame: Baseline
Plane between the sella point S and nasion point N measured on lateral cephalometric radiograph
Baseline
ANS-PNS plane
Time Frame: Baseline
Bispinal plane traced between the anterior nasal spine (ANS) and the posterior nasal spine (PNS) measured on lateral cephalometric radiograph
Baseline
GoGn plane
Time Frame: Baseline
Mandibular plane traced between Gonion and Gnathion points measured on lateral cephalometric radiograph
Baseline
Sella turcica length
Time Frame: Baseline
Distance between the Tuberculum sellae (TS) and the dorsum sella measured on lateral cephalometric radiograph
Baseline
Sella turcica diameter
Time Frame: Baseline
Distance between the Tuberculum Sellae (TS) and the farthest point on the inner wall of the sella measured on lateral cephalometric radiograph
Baseline
Sella turcica depth
Time Frame: Baseline
The distance of a line dropped perpendicularly from the interclinoidal distance to the deepest point of the sella floor measured on lateral cephalometric radiograph
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andrea Scribante, University of Pavia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 1, 2026

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

April 1, 2027

Study Registration Dates

First Submitted

April 21, 2025

First Submitted That Met QC Criteria

April 21, 2025

First Posted (Actual)

April 30, 2025

Study Record Updates

Last Update Posted (Actual)

November 19, 2025

Last Update Submitted That Met QC Criteria

November 14, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data will be available upon motivated request to the Principal Investigator.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tooth Abnormalities

Clinical Trials on Cephalometric tracing

Subscribe